HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junichi Kodama Selected Research

hepsin

9/2010Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma.
2/2009Expression of hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) in ovarian cancer.
9/2008Hepsin inhibits the cell growth of endometrial cancer.
1/2008Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.
2/2006Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junichi Kodama Research Topics

Disease

22Neoplasms (Cancer)
01/2019 - 02/2003
15Endometrial Neoplasms (Endometrial Cancer)
05/2012 - 12/2004
12Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2019 - 12/2004
7Ovarian Neoplasms (Ovarian Cancer)
01/2013 - 11/2003
5Neoplasm Metastasis (Metastasis)
05/2012 - 12/2003
5Lymphatic Metastasis
05/2009 - 07/2005
4Endometrial Hyperplasia
05/2012 - 01/2008
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2010 - 02/2002
3Ovarian Epithelial Carcinoma
05/2010 - 12/2003
3Adenocarcinoma
04/2010 - 02/2002
2Venous Thromboembolism
07/2013 - 01/2013
2Carcinoma (Carcinomatosis)
01/2013 - 02/2006
2Uterine Cervical Dysplasia
03/2005 - 03/2002
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
10/2020
1Pulmonary Embolism
07/2013
1Struma Ovarii
01/2013
1Obesity
07/2011
1Body Weight (Weight, Body)
07/2011
1Neutropenia
10/2010
1Leiomyosarcoma
09/2010
1Necrosis
09/2010
1Chronic Kidney Failure (Chronic Renal Failure)
05/2010
1Clear Cell Adenocarcinoma
04/2010
1Infections
08/2008
1Endometrioid Carcinoma
01/2008
1Hypercalcemia (Milk Alkali Syndrome)
02/2006
1Liver Cirrhosis (Hepatic Cirrhosis)
02/2006
1Carcinogenesis
03/2005
1Testicular Neoplasms (Testicular Cancer)
12/2004

Drug/Important Bio-Agent (IBA)

10Biological ProductsIBA
05/2012 - 05/2008
5hepsinIBA
09/2010 - 02/2006
5Proteins (Proteins, Gene)FDA Link
08/2008 - 03/2005
5Messenger RNA (mRNA)IBA
02/2006 - 12/2003
4Tumor Biomarkers (Tumor Markers)IBA
02/2012 - 02/2006
4HGF activatorIBA
06/2011 - 02/2009
4Paclitaxel (Taxol)FDA LinkGeneric
10/2010 - 02/2003
4Carboplatin (JM8)FDA LinkGeneric
10/2010 - 02/2003
4Indicators and Reagents (Reagents)IBA
04/2010 - 03/2005
3pirarubicinIBA
10/2010 - 02/2003
3matriptaseIBA
09/2010 - 02/2009
3Heparitin Sulfate (Heparan Sulfate)IBA
07/2005 - 12/2003
2PlatinumIBA
01/2019 - 02/2007
2fibrin fragment D (D-dimer)IBA
07/2013 - 01/2013
2Cadherins (E-Cadherin)IBA
05/2012 - 06/2011
2VimentinIBA
05/2012 - 06/2011
2Syndecan-1 (Syndecan 1)IBA
04/2010 - 03/2005
2Serine Proteases (Serine Protease)IBA
05/2009 - 01/2008
2heparanaseIBA
07/2005 - 12/2003
2DNA (Deoxyribonucleic Acid)IBA
03/2002 - 02/2002
1Imatinib Mesylate (Gleevec)FDA Link
10/2020
1taxaneIBA
01/2019
1Enoxaparin (Lovenox)FDA LinkGeneric
07/2013
1Fondaparinux (Arixtra)FDA Link
07/2013
1Hemoglobins (Hemoglobin)IBA
01/2013
1ThyroglobulinFDA Link
01/2013
1FibrinIBA
11/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012
1Epidermal Growth Factor (EGF)IBA
05/2012
1Small Interfering RNA (siRNA)IBA
05/2012
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
05/2012
1C-Reactive ProteinIBA
01/2012
1CholesterolIBA
07/2011
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2010
1squamous cell carcinoma-related antigenIBA
10/2010
1AnthracyclinesIBA
10/2010
1Proteoglycans (Proteoglycan)IBA
04/2010
1Versicans (Versican)IBA
04/2010
1Fetal Proteins (Fetoprotein)IBA
03/2010
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2010
1Glucose (Dextrose)FDA LinkGeneric
01/2010
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
08/2008
1Secretory Leukocyte Peptidase InhibitorIBA
05/2008
1Etoposide (VP 16)FDA LinkGeneric
03/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2007
1Cisplatin (Platino)FDA LinkGeneric
03/2007
1Epirubicin (Ellence)FDA LinkGeneric
03/2007
1Carcinoembryonic AntigenIBA
02/2006
1AgarIBA
02/2006
1CA-125 Antigen (CA 125 Antigen)IBA
02/2006
1CarbohydratesIBA
02/2006
1Parathyroid Hormone-Related ProteinIBA
02/2006
1CalciumIBA
02/2006
1ThymidineIBA
07/2005
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2005
1AntigensIBA
12/2004
1Cancer VaccinesIBA
12/2004
1AntibodiesIBA
12/2004
1A Kinase Anchor ProteinsIBA
01/2004

Therapy/Procedure

6Hysterectomy
01/2019 - 03/2002
4Drug Therapy (Chemotherapy)
01/2019 - 02/2003
4Lymph Node Excision (Lymph Node Dissection)
09/2011 - 03/2002
3Radiotherapy
02/2012 - 02/2007
3Combination Drug Therapy (Combination Chemotherapy)
10/2010 - 02/2007
3Therapeutics
10/2010 - 02/2007
2Neoadjuvant Therapy
01/2019 - 02/2002
2Adjuvant Chemotherapy
03/2007 - 02/2007
1Laparotomy
01/2013
1Perioperative Period
11/2012
1Chemoradiotherapy
02/2012
1Renal Dialysis (Hemodialysis)
05/2010